Integrated multiomics and spatial genomics analysis of 84 human donors revealed two distinct disease phases: an early phase with inflammatory microglia, reactive astrocytes, loss of somatostatin+ inhi

Neuropathology Score: 0.500 Price: $0.50 Alzheimer's disease human Status: extracted

What This Experiment Tests

Neuropathology experiment designed to assess clinical efficacy targeting N/A in human. Primary outcome: Integrated multiomics and spatial genomics analysis of 84 human donors revealed two distinct disease

Description

Quantitative neuropathology used to assign donors along disease pseudoprogression score; findings replicated in other major AD studies; BRAIN Initiative reference atlases integrated

TARGET GENE
N/A
MODEL SYSTEM
human
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
neuroinflammation
SOURCE
pmid_39402379
PRIMARY OUTCOME
Integrated multiomics and spatial genomics analysis of 84 human donors revealed two distinct disease phases: an early phase with inflammatory microglia, reactive astrocytes, loss of somatostatin+ inhibitory neurons, and oligodendrocyte precursor cell remyelination; and a later phase with exponential pathology increase and loss of excitatory and Pvalb+/Vip+ inhibitory neurons.

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.500 composite

Related Hypotheses (1)

Age-related neuroinflammation mimics early Alzheimer's disease pathology0.362

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.